{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:04:53Z","timestamp":1793228693426,"version":"4.5.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Inflammatory bowel disease (IBD) is a chronic immune-mediated disorder characterized by prolonged inflammation of the gastrointestinal tract. IBD can result from gut barrier dysfunction, altered gut microbiota, and abnormal intestinal immunity induced by environmental factors in genetically susceptible individuals. Proton pump inhibitors (PPIs) such as rabeprazole are frequently employed for gastric acid inhibition. However, long-term PPI administration can alter the intestinal microbiome composition, possibly worsening IBD severity. The present study revealed that tegoprazan, a potassium-competitive acid blocker, significantly improved colitis in mice and enhanced the intestinal epithelial barrier function. Tegoprazan alleviated gut microbiota dysbiosis and enhanced the growth of\n                    <jats:italic>Bacteroides vulgatus<\/jats:italic>\n                    . In turn,\n                    <jats:italic>B. vulgatus<\/jats:italic>\n                    alleviated intestinal inflammation by inhibiting epithelial adhesion of pathogenic bacteria. Unlike rabeprazole, tegoprazan did not induce gut dysbiosis. Our findings provide novel insights into the potential role of tegoprazan as an intestinal protectant for IBD and as a therapeutic agent for gastric acid-related diseases.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2022.870817","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T05:39:12Z","timestamp":1653457152000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["Novel Potassium-Competitive Acid Blocker, Tegoprazan, Protects Against Colitis by Improving Gut Barrier Function"],"prefix":"10.3389","volume":"13","author":[{"given":"Mijeong","family":"Son","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I Seul","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soochan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Woo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeyong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hee","family":"Cheon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nature06005","article-title":"Unravelling the Pathogenesis of Inflammatory Bowel Disease","volume":"448","author":"Xavier","year":"2007","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2019.09154","article-title":"Recent Updates on the Basic Mechanisms and Pathogenesis of Inflammatory Bowel Diseases in Experimental Animal Models","volume":"18","author":"Mizoguchi","year":"2020","journal-title":"Intest Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.09.056","article-title":"Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues","volume":"160","author":"Lee","year":"2021","journal-title":"Gastroenterology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/nrgastro.2017.117","article-title":"Proton-Pump Inhibitors: Understanding the Complications and Risks","volume":"14","author":"Malfertheiner","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.24.2947","article-title":"Long-Term Proton Pump Inhibitor Therapy and Risk of Hip Fracture","volume":"296","author":"Yang","year":"2006","journal-title":"JAMA"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12069","article-title":"Proton Pump Inhibitor Therapy Predisposes to Community-Acquired Streptococcus Pneumoniae Pneumonia","volume":"36","author":"de Jager","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2011.09.030","article-title":"Association Between Proton Pump Inhibitor Therapy and Clostridium Difficile Infection in a Meta-Analysis","volume":"10","author":"Deshpande","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310376","article-title":"Proton Pump Inhibitors Affect the Gut Microbiome","volume":"65","author":"Imhann","year":"2016","journal-title":"Gut"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1159\/000455008","article-title":"Gastric Acid Suppression is Associated With an Increased Risk of Adverse Outcomes in Inflammatory Bowel Disease","volume":"95","author":"Shah","year":"2017","journal-title":"Digestion"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/1574-6976.12027","article-title":"Survival in Hostile Territory: The Microbiota of the Stomach","volume":"37","author":"Yang","year":"2013","journal-title":"FEMS Microbiol Rev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.pharmthera.2005.05.005","article-title":"Potassium-Competitive Acid Blockade: A New Therapeutic Strategy in Acid-Related Diseases","volume":"108","author":"Andersson","year":"2005","journal-title":"Pharmacol Ther"},{"key":"B12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.pharmthera.2016.08.001","article-title":"Potassium-Competitive Acid Blockers: Advanced Therapeutic Option for Acid-Related Diseases","volume":"168","author":"Inatomi","year":"2016","journal-title":"Pharmacol Ther"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1021\/jm300318t","article-title":"Discovery of a Novel Pyrrole Derivative 1-[5-(2-Fluorophenyl)-1-(Pyridin-3-Ylsulfonyl)-1H-Pyrrol-3-Yl]-N-Methylmethanamin E Fumarate (TAK-438) as a Potassium-Competitive Acid Blocker (P-CAB)","volume":"55","author":"Arikawa","year":"2012","journal-title":"J Med Chem"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1053\/j.gastro.2021.08.005","article-title":"Regular Use of Proton Pump Inhibitor and the Risk of Inflammatory Bowel Disease: Pooled Analysis of 3 Prospective Cohorts","volume":"161","author":"Xia","year":"2021","journal-title":"Gastroenterology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13841","article-title":"Proton Pump Inhibitors Enhance Intestinal Permeability via Dysbiosis of Gut Microbiota Under Stressed Conditions in Mice","volume":"32","author":"Takashima","year":"2020","journal-title":"Neurogastroenterol Motil"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1038\/s41598-020-59550-x","article-title":"The Effects of a Multispecies Synbiotic on Microbiome-Related Side Effects of Long-Term Proton Pump Inhibitor Use: A Pilot Study","volume":"10","author":"Horvath","year":"2020","journal-title":"Sci Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.118.254904","article-title":"Effects of Tegoprazan, a Novel Potassium-Competitive Acid Blocker, on Rat Models of Gastric Acid-Related Disease","volume":"369","author":"Kim","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1998.00728.x","article-title":"Chronic Experimental Colitis Induced by Dextran Sulphate Sodium (DSS) Is Characterized by Th1 and Th2 Cytokines","volume":"114","author":"Dieleman","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3791\/51297","article-title":"DNBS\/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat","author":"Morampudi","year":"2014","journal-title":"J Vis Exp"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/nri3661","article-title":"Cytokines in Inflammatory Bowel Disease","volume":"14","author":"Neurath","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/01.MIB.0000218764.06959.91","article-title":"Critical Role of IL-17 Receptor Signaling in Acute TNBS-Induced Colitis","volume":"12","author":"Zhang","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00280","article-title":"Central Role of the Gut Epithelial Barrier in the Pathogenesis of Chronic Intestinal Inflammation: Lessons Learned From Animal Models and Human Genetics","volume":"4","author":"Pastorelli","year":"2013","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10565-005-0085-6","article-title":"The Caco-2 Cell Line as a Model of the Intestinal Barrier: Influence of Cell and Culture-Related Factors on Caco-2 Cell Functional Characteristics","volume":"21","author":"Sambuy","year":"2005","journal-title":"Cell Biol Toxicol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9478630","article-title":"Probiotic Species in the Modulation of Gut Microbiota: An Overview","volume":"2018","author":"Azad","year":"2018","journal-title":"BioMed Res Int"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i29.8787","article-title":"Role of the Normal Gut Microbiota","volume":"21","author":"Jandhyala","year":"2015","journal-title":"World J Gastroenterol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1742-7843.2005.pto960202.x","article-title":"Gastric Juice: A Barrier Against Infectious Diseases","volume":"96","author":"Martinsen","year":"2005","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/S0928-8244(03)00228-1","article-title":"Anti-Adhesion Therapy of Bacterial Diseases: Prospects and Problems","volume":"38","author":"Ofek","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.63.1.356-359.1995","article-title":"Rapid Disruption of Epithelial Barrier Function by Salmonella Typhimurium is Associated With Structural Modification of Intercellular Junctions","volume":"63","author":"Jepson","year":"1995","journal-title":"Infect Immun"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2018.00170","article-title":"Epithelial-Microbial Diplomacy: Escalating Border Tensions Drive Inflammation in Inflammatory Bowel Disease","volume":"17","author":"King","year":"2019","journal-title":"Intest Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218713","article-title":"COVID-19 Global Rheumatology Alliance Registry, Anti-IL-6 Therapy, Shared Decision-Making and Patient Outcomes. Response to: 'Correspondence on 'Characteristics Associated With Hospitalisation for COVID-19 in People With Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance Physician-Reported Registry' by Gianfrancesco Et al. Compassionate Use of Tocilizumab in Severe COVID-19 With Hyperinflammation Prior to Advent of Clinical Trials - a Real-World District General Hospital Experience' by Khan Et Al, 'Comment on 'Characteristics Associated With Hospitalisation for COVID-19 in People With Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance Physician-Reported Registry' by Gianfrancesco M Et Al' by Andreica Et Al and 'COVID-19 Outcomes in Patients With Systemic Autoimmune Diseases Treated With Immunomodulatory Drugs' by Ansarin Et al","author":"Gianfrancesco","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"12727","DOI":"10.1038\/s41598-018-30932-6","article-title":"Characterization of Bacterial Microbiota Compositions Along the Intestinal Tract in Pigs and Their Interactions and Functions","volume":"8","author":"Crespo-Piazuelo","year":"2018","journal-title":"Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13414","article-title":"The Binding Selectivity of Vonoprazan (TAK-438) to the Gastric H+, K+ -ATPase","volume":"42","author":"Scott","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4196\/kjpp.2014.18.4.279","article-title":"A Review on Chemical-Induced Inflammatory Bowel Disease Models in Rodents","volume":"18","author":"Randhawa","year":"2014","journal-title":"Korean J Physiol Pharmacol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1264\/jsme2.ME17017","article-title":"Microbial Ecology Along the Gastrointestinal Tract","volume":"32","author":"Hillman","year":"2017","journal-title":"Microbes Environ"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2012.07.004","article-title":"Transient Inability to Manage Proteobacteria Promotes Chronic Gut Inflammation in TLR5-Deficient Mice","volume":"12","author":"Carvalho","year":"2012","journal-title":"Cell Host Microbe"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4161\/gmic.25486","article-title":"Altered Enteric Microbiota Ecology in Interleukin 10-Deficient Mice During Development and Progression of Intestinal Inflammation","volume":"4","author":"Maharshak","year":"2013","journal-title":"Gut Microbes"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1186\/1757-4749-6-22","article-title":"Characterization of Bacterial Community Shift in Human Ulcerative Colitis Patients Revealed by Illumina Based 16S rRNA Gene Amplicon Sequencing","volume":"6","author":"Walujkar","year":"2014","journal-title":"Gut Pathog"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0706625104","article-title":"Molecular-Phylogenetic Characterization of Microbial Community Imbalances in Human Inflammatory Bowel Diseases","volume":"104","author":"Frank","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/ismej.2013.80","article-title":"Dysbiosis in Inflammatory Bowel Diseases: The Oxygen Hypothesis","volume":"7","author":"Rigottier-Gois","year":"2013","journal-title":"ISME J"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/nature11234","article-title":"Structure, Function and Diversity of the Healthy Human Microbiome","volume":"486","author":"Human Microbiome Project","year":"2012","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.71.6.3184-3191.2005","article-title":"Host Distributions of Uncultivated Fecal Bacteroidales Bacteria Reveal Genetic Markers for Fecal Source Identification","volume":"71","author":"Dick","year":"2005","journal-title":"Appl Environ Microbiol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.2741\/3603","article-title":"Beneficial Effects of Bacteroides Fragilis Polysaccharides on the Immune System","volume":"15","author":"Troy","year":"2010","journal-title":"Front Biosci (Landmark Ed)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.2.1118","article-title":"Role of Commensal Bacteria in Development of Gut-Associated Lymphoid Tissues and Preimmune Antibody Repertoire","volume":"172","author":"Rhee","year":"2004","journal-title":"J Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1126\/science.1224686","article-title":"Honor Thy Gut Symbionts Redux","volume":"336","author":"Gordon","year":"2012","journal-title":"Science"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.42.2.783-788.1983","article-title":"Enhancement of Experimental Ulcerative Colitis by Immunization With Bacteroides Vulgatus","volume":"42","author":"Onderdonk","year":"1983","journal-title":"Infect Immun"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.6.2969-2974.1999","article-title":"Differential Induction of Colitis and Gastritis in HLA-B27 Transgenic Rats Selectively Colonized With Bacteroides Vulgatus or Escherichia Coli","volume":"67","author":"Rath","year":"1999","journal-title":"Infect Immun"},{"key":"B47","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.chom.2011.04.009","article-title":"Commensal Bacteroides Species Induce Colitis in Host-Genotype-Specific Fashion in a Mouse Model of Inflammatory Bowel Disease","volume":"9","author":"Bloom","year":"2011","journal-title":"Cell Host Microbe"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20040","article-title":"CD4(+) T Lymphocytes Mediate Colitis in HLA-B27 Transgenic Rats Monoassociated With Nonpathogenic Bacteroides Vulgatus","volume":"13","author":"Hoentjen","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/s0016-5085(03)00672-3","article-title":"Bacteroides Vulgatus Protects Against Escherichia Coli-Induced Colitis in Gnotobiotic Interleukin-2-Deficient Mice","volume":"125","author":"Waidmann","year":"2003","journal-title":"Gastroenterology"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.033714","article-title":"Bacteroides Vulgatus and Bacteroides Dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis","volume":"138","author":"Yoshida","year":"2018","journal-title":"Circulation"},{"key":"B51","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s40168-019-0746-y","article-title":"Commensal-Derived Metabolites Govern Vibrio Cholerae Pathogenesis in Host Intestine","volume":"7","author":"You","year":"2019","journal-title":"Microbiome"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2015.01.004","article-title":"How Bacterial Pathogens Colonize Their Hosts and Invade Deeper Tissues","volume":"17","author":"Ribet","year":"2015","journal-title":"Microbes Infect"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/nature07008","article-title":"A Microbial Symbiosis Factor Prevents Intestinal Inflammatory Disease","volume":"453","author":"Mazmanian","year":"2008","journal-title":"Nature"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.11.6112","article-title":"Bacterial-Reactive T Regulatory Cells Inhibit Pathogenic Immune Responses to the Enteric Flora","volume":"169","author":"Cong","year":"2002","journal-title":"J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.870817\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T05:39:14Z","timestamp":1653457154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.870817\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":54,"alternative-id":["10.3389\/fimmu.2022.870817"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.870817","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,25]]},"article-number":"870817"}}